Glomerular Injury Findings in Patients with Thalassemia Minor
Open Access
- 1 April 2026
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (7) , 3209
Abstract
Renal involvement in β-thalassemia minor (β-TMin) has been described mainly in case reports and small observational studies, and its clinical significance remains incompletely characterized. Using real-world data from routinely collected electronic medical records, we performed a retrospective cohort study including 1516 adult patients with β-TMin insured by Clalit Healthcare Services to explore renal abnormalities identified during routine clinical care. Urine testing for hematuria, microalbuminuria, and proteinuria was not performed systematically but was ordered at clinicians’ discretion, resulting in evaluation of a clinically selected subset of patients. Among those tested, hematuria, microalbuminuria, and proteinuria were commonly documented, often in the absence of hypertension, diabetes mellitus, congestive heart failure, or impaired kidney function, consistent with largely subclinical renal involvement. Patients who underwent urine testing were older and had more comorbidities than untested patients, indicating potential selection bias. Correlation analyses showed weak associations between hematological and renal parameters, while ferritin levels correlated modestly with selected proteinuria measures. Due to the retrospective design and non-systematic urine assessment, population-level prevalence and clinical impact cannot be determined. Therefore, prospective studies with standardized renal evaluations are needed to better characterize the frequency, mechanisms, and clinical relevance of renal abnormalities in β-TMin.Keywords
This publication has 39 references indexed in Scilit:
- Molecular Basis and Genetic Modifiers of ThalassemiaHematology/Oncology Clinics of North America, 2023
- Clinical features and risk factors of renal dysfunctions in thalassemic patientsInternational Urology and Nephrology, 2023
- Current status of beta‐thalassemia and its treatment strategiesMolecular Genetics & Genomic Medicine, 2021
- Beta Thalassemia: New Therapeutic Options Beyond Transfusion and Iron ChelationDrugs, 2020
- Clinical Classification, Screening and Diagnosis for ThalassemiaHematology/Oncology Clinics of North America, 2018
- Thalassemia bone disease: the association between nephrolithiasis, bone mineral density and fracturesOsteoporosis International, 2013
- Splenectomy is a risk factor for developing hyperuricemia and nephrolithiasis in patients with thalassemia intermedia: A retrospective studyBlood Cells, Molecules, and Diseases, 2012
- Renal complications in transfusion-dependent beta thalassaemiaBlood Reviews, 2010
- Serum ferritin: Past, present and futureBiochimica et Biophysica Acta (BBA) - General Subjects, 2010
- Renal function in children with β-thalassemia major and thalassemia intermediaPediatric Nephrology, 2008